Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,450
NCT02934360
TR(ACE) Assay Clinical Specimen Study
Phase: N/A
Role: Lead Sponsor
Start: Sep 30, 2016
Completion: Apr 30, 2018
NCT05625529
ExoLuminate Study for Early Detection of Pancreatic Cancer
Start: Dec 19, 2022
Completion: Jan 1, 2028